A Placebo-Controlled, Randomized, Double-Blind, Parallel Group, Drug Interaction Study to Evaluate the Safety, Tolerability and Effect on Atorvastatin Pharmacokinetics of ETC-1002 Added to Atorvastatin 10 mg/Day in Subjects With Hypercholesterolemia
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2015
Price : $35 *
At a glance
- Drugs Bempedoic acid (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Esperion Therapeutics
- 03 Sep 2013 Top-line results have been reported in an Esperion Therapeutics media release.
- 30 Aug 2013 Top-line results from this study will be announced on 3 September 2013, according to an Esperion Therapeutics media release.
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History